Morgan L Prust
Overview
Explore the profile of Morgan L Prust including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prust M, Kaunda K, Salasky V, Mateyo K, Bwalya M, Chilando M, et al.
Neurology
. 2024 Dec;
104(1):e210132.
PMID: 39666925
Objectives: Neurocritical illnesses occur disproportionately in countries with limited health care capacity. Identifying risk factors of reversible neurodeterioration may improve care in resource-limited settings. We investigated whether early neurodeterioration (END)...
2.
Prust M, Forman R, Ovbiagele B
Nat Rev Neurol
. 2024 Jan;
20(4):207-221.
PMID: 38228908
Stroke is the second leading cause of death and the third leading cause of disability worldwide. Though the burden of stroke worldwide seems to have declined in the past three...
3.
Shrestha G, Nepal G, Prabhakar H, Prust M
Lancet Glob Health
. 2023 Aug;
11(9):e1343.
PMID: 37591582
No abstract available.
4.
Mikhaiel J, Parasram M, Manning T, Al-Dulaimi M, Barnes E, Falcone G, et al.
Neurologist
. 2023 Aug;
29(1):14-16.
PMID: 37582680
Introduction: Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal neurodegenerative condition caused by prion proteins. Cortical and subcortical diffusion-weighted imaging restriction on magnetic resonance imaging (MRI) is associated with sCJD. Posterior...
5.
Hong C, Prust M, Peter Manes R, Rimmer R, Omay S
J Neurosurg Case Lessons
. 2023 Feb;
5(8).
PMID: 36806010
Background: Superimposed intracranial infection is an uncommon but clinically significant complication in patients with active coronavirus disease 2019 (COVID-19), particularly in those with predisposing immunocompromising conditions. Observations: The authors describe...
6.
Prust M, Mbonde A, Rubinos C, Shrestha G, Komolafe M, Saylor D, et al.
Neurocrit Care
. 2022 Jul;
37(2):583-592.
PMID: 35840824
Acute neurologic illnesses (ANI) contribute significantly to the global burden of disease and cause disproportionate death and disability in low-income and middle-income countries (LMICs) where neurocritical care resources and expertise...
7.
Prust M, Saylor D, Zimba S, Sarfo F, Shrestha G, Berkowitz A, et al.
Stroke
. 2022 Jan;
53(3):e108-e117.
PMID: 35045720
Stroke is the second leading cause of death and disability worldwide, with a disproportionate burden on low- and middle-income countries. Critical elements of guideline-based stroke care developed in high-income countries...
8.
Prust M, Nutakki A, Habanyama G, Chishimba L, Chomba M, Mataa M, et al.
Neurol Clin Pract
. 2022 Jan;
11(6):e840-e847.
PMID: 34992967
Background And Objectives: Preventing complications of stroke such as poststroke aspiration pneumonia (PSAP) may improve stroke outcomes in resource-limited settings. We investigated the incidence and associated mortality of PSAP in...
9.
Boehme A, Doyle K, Thakur K, Roh D, Park S, Agarwal S, et al.
Neurocrit Care
. 2021 Jun;
36(1):89-96.
PMID: 34184176
Background: Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications,...
10.
Thakur K, Miller E, Glendinning M, Al-Dalahmah O, Banu M, Boehme A, et al.
Brain
. 2021 Apr;
144(9):2696-2708.
PMID: 33856027
Many patients with SARS-CoV-2 infection develop neurological signs and symptoms; although, to date, little evidence exists that primary infection of the brain is a significant contributing factor. We present the...